Twin Peaks Wealth Advisors’s CONMED CNMD Stock Holding History

Twin Peaks Wealth Advisors’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-92	Closed	-$3.25K	–	618
2026 Q1	$3.25K	Buy	+92	New	+$3.74K	﹤0.01%	1544

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Twin Peaks Wealth Advisors's CNMD Position: Q2 2026 in Review

Twin Peaks Wealth Advisors sold out of CONMED (CNMD) in Q2 2026, closing a stake of 92 shares — an estimated $3.25K sold.

Twin Peaks Wealth Advisors first reported a position in CNMD in Q1 2026 and held it in 1 quarter. The position peaked at $3.25K in Q1 2026. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

Twin Peaks Wealth Advisors reported no remaining CONMED position as of Q2 2026 after selling out during the quarter.
Twin Peaks Wealth Advisors sold 92 CONMED shares in Q2 2026, an estimated $3.25K.
Twin Peaks Wealth Advisors first reported a position in CONMED in Q1 2026 and held it in 1 quarter.
Twin Peaks Wealth Advisors's CONMED position peaked at $3.25K in Q1 2026.
246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Twin Peaks Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.